Why the study?
What are the outcomes of pericardiocentesis and systemic therapy in patients with metastatic breast cancer and pericardial effusions?
Population
35 patients with metastatic breast cancer and pericardial effusions
Design
Case_series
Follow-up
median survival 13.2 months
Authors
Loading...
Pericardiocentesis may relieve tamponade in metastatic breast cancer; case series leaves open optimal systemic therapy integration.
What are the outcomes of pericardiocentesis and systemic therapy in patients with metastatic breast cancer and pericardial effusions?
In patients with metastatic breast cancer, pericardiocentesis for cardiac tamponade is lifesaving and often requires no further local treatment when combined with systemic therapy.
Woll et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: